WHO ICTRP trial
A study of belumosudil in children with chronic graft versus host disease…
CTIS2024-511508-18-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-511508-18-00 |
|---|---|
| Public title | A study of belumosudil in children with chronic graft versus host disease (schoolROCK). |
| Scientific title | An open-label, Phase 1/2, multicenter study of belumosudil in children aged 1 to <18 years requiring systemic treatment for active moderate-to-severe chronic graft versus host disease (cGVHD). - DFI17893 |
| Primary sponsor | Sanofi-Aventis Recherche & Developpement |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Turkey;United Kingdom;Canada;Japan;United States;Israel;China;France;Germany;Belgium;Italy;Netherlands;Spain |
| Conditions | Chronic graft versus host disease. MedDRA version: 27.0Level: PTClassification code: 10066261Term: Chronic graft versus host disease Class: 100000004870;Therapeutic area: Diseases [C] - Immune System Diseases [C20] |
| Interventions | Product Name: belumosudil, Product Code:PRD12275526, Pharmaceutical Form: ORAL SUSPENSION, Other descriptive name: , Strength: , Product Name: SAR445761 - belumosudil, Product Code:PRD10413339, Pharmaceutical Form: FILM-COATED TABLET, Other… |
| Registration date | Apr 6, 2025 |
| Target size | 50 |
| Secondary IDs | U1111-1281-0103 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: